Fundz

Taro Completes Acquisition Of Alchemee

PRIVATEFeb 28, 2022

Acquiring Company

Taro

Acquired Company

Alchemee

ManufacturingHealth CareSustainabilityScience And EngineeringGovernment And Military

Description

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today announced the completion of its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The acquisition includes Alchemee’s business and assets worldwide, including the Proactiv® brand.

Other recent acquisitions in Sustainability and Science And Engineering

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Taro, and when

When Taro changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Taro raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Taro, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Taro. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Taro

About

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Taro makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Taro's next move

Learn about Strategic plan

Frequently asked

Who acquired Alchemee?

Alchemee was acquired by Taro. The deal was reported on February 28, 2022. Taro Pharmaceutical Industries Ltd. Taro is privately held and operates in Manufacturing.

When did Taro acquire Alchemee?

Taro's acquisition of Alchemee was reported on February 28, 2022. Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today announced the completion of its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Alchemee do?

At Alchemee, we aspire to inspire. We are alchemists at heart, harnessing science to create powerful wellness solutions. It is privately held, operating in Sustainability.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.